K252421

Substantially Equivalent

JLK-NCCT

Applicant: JLK, Inc.
Product code: QAS
Advisory panel: Radiology
Date received: 2025-08-01
Decision date: 2026-03-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seoul, KR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.